3-Amino-1,2-propanediol → 1-[(S)-6-bromo-5-(o-chlorophenyl)-2,3-dihydro-1,3-dimethyl-2-oxo-1H-1,4-benzodiazepin-7-yl]-3-[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]urea
反応式
[Br:1][C:2]1[C:7]2[C:8]([C:16]3[CH:21]=[CH:20][CH:19]=[CH:18][C:17]=3[Cl:22])=[N:9][C@@H:10]([CH3:15])[C:11](=[O:14])[N:12]([CH3:13])[C:6]=2[CH:5]=[CH:4][C:3]=1[N:23]=[C:24]=[O:25].N[C:27]1[CH:28]=CC2N(C)C(=O)[C@H](C)N=C(C3C=CC=CC=3Cl)C=2[C:47]=1Br.[NH2:49][CH2:50][CH:51]([OH:54])[CH2:52][OH:53]>CC(C)=O.O>[Br:1][C:2]1[C:7]2[C:8]([C:16]3[CH:21]=[CH:20][CH:19]=[CH:18][C:17]=3[Cl:22])=[N:9][C@@H:10]([CH3:15])[C:11](=[O:14])[N:12]([CH3:13])[C:6]=2[CH:5]=[CH:4][C:3]=1[NH:23][C:24]([NH:49][CH2:50][CH:51]1[CH2:52][O:53][C:27]([CH3:28])([CH3:47])[O:54]1)=[O:25]参加物
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
A solution of (S)-[6-bromo-5-(o-chlorophenyl)-2,3-dihydro-1,3-dimethyl-2-oxo-1H-1,4-benzodiazepin-7-yl]isocyanate [obtained in accordance with details in Example 1(f) from 4 g (0.01 mol) of (S)-7-amino-6-bromo-5-(o-chlorophenyl)-1,3-dihydro-1,3-dimethyl-2H-1,4-benzodiazepin-2-one] in acetone is treated with a solution of 3.8 g (0.04 mol) of 3-amino-1,2-propanediol in 10 ml of water and 50 ml of acetone, the mixture is stirred at room temperature for 12 hours and extracted with methylene chloride. The organic extract is dried over sodium sulphate and evaporated, whereupon the residue is chromatographed on silica gel while eluting with chloroform. There is obtained 1-[(S)-6-bromo-5-(o-chlorophenyl)-2,3-dihydro-1,3-dimethyl-2-oxo-1H-1,4-benzodiazepin-7-yl]-3-[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]urea of melting point 135° (decomposition); [α]25D =+7.6° (0.8 percent solution in methanol).
後処理
- extractionextracted with methylene chloride
- extractionThe organic extract
- dry with materialis dried over sodium sulphate
- customevaporated, whereupon the residue
- customis chromatographed on silica gel
- washwhile eluting with chloroform
出典と根拠
- ORDレコード
- ord-4866b5f706aa405695d8bd3c8f00db3c
- 出典データセット
- uspto-grants-1984_10
- 特許番号
- US04474777
反応ノート
読み込み中…